文献速递生殖医学

卵巢组织冷冻保存用于生育力保存的有效性:545例病例的经验教训

Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases.
PubMed 文献 · Hum Reprod · 2017-01-01

该研究回顾性分析了1997至2013年间单中心545例接受卵巢组织冷冻保存(OTC)的患者,并於2015年3月发放前瞻性问卷。自体移植后活产率为33%,92例可评估患者中31.5%卵巢早衰,52例尝试自然受孕者中37例成功(71%)。

要点

  • 545例OTC患者平均年龄22.3±8.8岁,79%为肿瘤指征,17.5%为良性妇科疾病,3.5%为POF遗传风险。
  • 21例(3.9%)行自体移植,7例获得健康活产,移植后活产率33%。
  • 92例可评估患者中31.5%卵巢早衰,68.5%卵巢功能持续;52例尝试自然受孕者中37例成功(71%)。

核心结论

  • 本队列中,OTC患者卵巢早衰率、回归率和自体移植后妊娠率分别为31.5%、4.4%和33%。
  • 研究结果证实卵巢皮质自体移植后约30%的妊娠率,但也强调评估OTC真实有效性的困难。

研究设计与样本

  • 回顾性分析单中心1997年至2013年间因生育力保存行卵巢组织冷冻保存的病例,并通过冷冻库数据库及2015年3月发放的前瞻性问卷进行随访。
  • 共纳入545例接受OTC的患者。

主要发现

  • OTC时平均年龄22.3±8.8岁;肿瘤指征占79%,良性妇科病理占17.5%,POF遗传风险占3.5%。
  • 29%的患者OTC时年龄小于18岁,15%为青春期前;10%的患者因病死亡。
  • 21例(3.9%)接受自体移植,其中7例分娩健康婴儿,移植后活产率为33%。
  • 451例收到问卷,143例同意回复(32%);回复者中36%无法评估卵巢功能。
  • 92例可评估患者中31.5%绝经,68.5%显示卵巢功能持续;52例尝试自然受孕者中37例成功(71%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 问卷参与率为32%。
  • 随访时间有限(平均7.6±3.5年)。
  • 仅使用临床标准评估卵巢功能,难以准确评估POF风险和OTC效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How effective is ovarian tissue cryopreservation (OTC)? SUMMARY ANSWER: In our cohort of patients who underwent OTC, premature ovarian failure (POF) rates, return rates and pregnancy rates after autotransplantation were 31.5, 4.4 and 33%, respectively. WHAT IS KNOWN ALREADY: OTC for fertility purposes has been performed for >20 years now. With over 86 live births reported worldwide and success rates of ~30% after autotransplantation of frozen-thawed ovarian cortex, the procedure should no longer be considered experimental. However, very few publications report the efficacy of this procedure. STUDY DESIGN, SIZE, DURATION: Cases of ovarian tissue cryobanking for fertility preservation performed between 1997 and 2013 in a single institution were reviewed by analysis of the cryobank database and a prospective questionnaire sent out in March 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: There were 545 patients who underwent OTC during this period. The analysis included indications for OTC, survival rates, ovarian function and spontaneous pregnancies after OTC, come-back rates for ovarian tissue transplantation, pregnancy rates after transplantation, and complication and satisfaction rates. MAIN RESULTS AND THE ROLE OF CHANCE: OTC was performed in this cohort at a mean age of 22.3 ± 8.8 years for oncological indications (79%), benign gynecological pathologies (17.5%) and genetic risks of POF (3.5%). Of the 545 patients, 29% were under 18 years of age at the time of OTC and 15% were prepubertal. While 10% of patients died from their disease, 21 patients (3.9%) underwent autotransplantation, 7 of whom delivered a healthy baby, yielding a post-transplantation live birth rate of 33%. Of 451 patients who were sent the questionnaire, 143 agreed to respond (32%). Nevertheless, ovarian function could not be evaluated in 36% of those who answered. Of 92 evaluable patients, 31.5% were menopausal and 68.5% showed persistent ovarian function. Of 52 women who attempted to conceive naturally, 37 were successful (71%). Among 140 patients who answered the questionnaire, 96% were satisfied with the procedure and only 1 major complication (intra-abdominal hemorrhage) was encountered. Among all the patients, 12% have donated their ovarian cortex for research purposes or have had it destroyed. LIMITATIONS, REASONS FOR CAUTION: The questionnaire participation rate (32%), limited follow-up (mean 7.6 ± 3.5 years) and use of only clinical criteria for evaluation of ovarian function made it difficult to accurately assess the risk of POF and efficiency of OTC. WIDER IMPLICATIONS OF THE FINDINGS: Our findings confirm a 30% pregnancy rate after ovarian cortex autotransplantation but also stress the difficulties of evaluating the real efficacy of OTC. STUDY FUNDING/COMPETING INTEREST(S): No funding was sought for this study and none of the authors have any conflict of interest. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Registration ID: CRYOFONOV01.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017. PMID: 28333228. doi:10.1093/humrep/dex040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。